0 items USD 0.00Search
Your search for "globaldata amyloidosis global clinical trials review h2 2018" gave back 83406 results.
Amyloidosis is a clinical disorder caused by extracellular or intracellular deposition of insoluble abnormal amyloid fibrils that affect the normal...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Amyloidosis is a clinical disorder caused by extracellular or intracellular deposition of insoluble abnormal amyloid fibrils that affect the normal...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Hereditary Amyloidosis is one of the amyloidosis disease that is caused by inherited genetic mutation. The “Hereditary Amyloidosis Treatment Industry...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global AL Amyloidosis Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR...
Catalog:
LPI
February 2023
Price: USD 3,660.00
According to our Publisher latest study, the global AL Amyloidosis Therapeutics market size was valued at USD million in 2022 and is forecast to a...
Catalog:
GIR
March 2023
Price: USD 3,480.00
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Amyloidosis is a clinical disorder caused by extracellular or intracellular deposition of insoluble abnormal amyloid fibrils that affect the normal...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Amyloidosis is a clinical disorder caused by extracellular or intracellular deposition of insoluble abnormal amyloid fibrils that affect the normal...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Amyloidosis is a clinical disorder caused by extracellular or intracellular deposition of insoluble abnormal amyloid fibrils that affect the normal...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global AL Amyloidosis Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
March 2023
Price: USD 4,480.00
Hereditary Amyloidosis is one of the amyloidosis disease that is caused by inherited genetic mutation. Highlights The global Hereditary Amyloidosis...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The most common kind of systemic amyloidosis is the amyloid light chain (AL) amyloidosis, sometimes referred to as primary amyloidosis. Systemic...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Hereditary Amyloidosis is one of the amyloidosis disease that is caused by inherited genetic mutation. Market Analysis and Insights: Global...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
